β-Galactosidase Antibodies

Santa Cruz Biotechnology features a diverse variety of β-Galactosidase monoclonal antibodies for research applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). β-Galactosidase is an enzyme that catalyzes the hydrolysis of β-galactosides into monosaccharides, playing a vital role in lactose metabolism and cellular signaling. β-Galactosidase serves as a reporter enzyme in gene expression studies and aids in the diagnosis of specific genetic disorders. Understanding β-Galactosidase function and regulation provides valuable insights into metabolic pathways and potential therapeutic targets. β-Galactosidase research has revealed significant roles in developmental biology and cell senescence studies. Ongoing investigations continue to uncover new functions of β-Galactosidase in cellular processes and disease mechanisms. Recent advances have highlighted β-Galactosidase involvement in aging-related cellular changes and tissue development. β-Galactosidase research using Santa Cruz Biotechnology monoclonal antibodies enables scientists to make meaningful contributions to enzyme biology and disease research.